Sopharma AD (WAR:SPH) — Stock Price
Sopharma AD (WAR:SPH) is currently trading at zł7.68 PLN, up 6.37% today. Over the past 52 weeks, shares have ranged between zł7.12 and zł12.75. This page tracks Sopharma AD's live share price on the WAR exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Sopharma AD.
Sopharma AD (SPH) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Sopharma AD's daily closing share price and trading volume on the WAR exchange over the past year, giving a clear view of recent price momentum and liquidity.
Sopharma AD Income Statement — Revenue, Profit & Earnings by Year
Sopharma AD's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | zł2.13 Billion | zł1.89 Billion | zł1.66 Billion | zł1.60 Billion | zł1.44 Billion |
| Cost of Revenue | zł1.68 Billion | zł1.47 Billion | zł1.31 Billion | zł1.26 Billion | zł1.14 Billion |
| Gross Profit | zł454.04 Million | zł415.51 Million | zł357.00 Million | zł341.36 Million | zł303.09 Million |
| Research & Development | — | — | — | — | — |
| SG&A | zł18.57 Million | zł218.14 Million | zł33.43 Million | zł33.02 Million | zł34.65 Million |
| Total Operating Expenses | zł372.28 Million | zł317.97 Million | zł261.99 Million | zł268.93 Million | zł248.99 Million |
| Operating Income | zł81.76 Million | zł98.11 Million | zł89.57 Million | zł89.55 Million | zł45.80 Million |
| EBITDA | zł165.89 Million | zł177.28 Million | zł143.19 Million | zł142.73 Million | zł90.48 Million |
| EBIT | zł106.53 Million | zł121.41 Million | zł91.09 Million | zł89.55 Million | zł43.85 Million |
| Interest Expense | zł14.44 Million | zł10.21 Million | zł6.01 Million | zł10.79 Million | zł12.41 Million |
| Income Before Tax | zł92.08 Million | zł110.90 Million | zł87.03 Million | zł97.57 Million | zł31.44 Million |
| Income Tax Expense | zł11.65 Million | zł11.82 Million | zł9.15 Million | zł5.87 Million | zł6.16 Million |
| Net Income | zł76.31 Million | zł95.21 Million | zł71.12 Million | zł89.50 Million | zł29.80 Million |
Sopharma AD Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Sopharma AD's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | zł1.80 Billion | zł1.51 Billion | zł1.26 Billion | zł1.20 Billion | zł1.24 Billion |
| Total Current Assets | zł849.38 Million | zł781.89 Million | zł578.38 Million | zł571.23 Million | zł612.18 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | zł-271.00K | zł-140.00K | — | — |
| Net Receivables | zł334.83 Million | zł283.83 Million | zł237.35 Million | zł242.11 Million | zł257.39 Million |
| Inventory | zł451.41 Million | zł331.44 Million | zł279.09 Million | zł255.95 Million | zł287.57 Million |
| Property, Plant & Equipment | — | — | zł376.26 Million | zł362.39 Million | zł395.87 Million |
| Goodwill | zł5.54 Million | zł3.44 Million | zł3.52 Million | zł13.42 Million | zł13.27 Million |
| Total Liabilities | zł953.18 Million | zł760.54 Million | zł537.67 Million | zł546.11 Million | zł675.52 Million |
| Total Current Liabilities | zł771.47 Million | zł609.19 Million | zł396.56 Million | zł423.89 Million | zł544.45 Million |
| Long-term Debt | zł64.65 Million | zł55.53 Million | zł39.49 Million | zł42.91 Million | zł34.57 Million |
| Net Debt | zł445.12 Million | zł205.15 Million | zł259.38 Million | zł284.85 Million | zł363.46 Million |
| Total Stockholder Equity | zł823.92 Million | zł738.33 Million | zł706.07 Million | zł646.98 Million | zł553.27 Million |
| Retained Earnings | zł665.36 Million | zł579.35 Million | zł511.29 Million | zł444.63 Million | zł360.77 Million |
Sopharma AD Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Sopharma AD generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | zł76.73 Million | zł45.03 Million | zł124.62 Million | zł-75.96 Million | zł-179.41 Million |
| Capital Expenditures | zł121.39 Million | zł43.29 Million | zł23.22 Million | zł27.11 Million | zł27.01 Million |
| Free Cash Flow | zł-44.66 Million | zł1.75 Million | zł101.40 Million | zł-103.07 Million | zł-206.42 Million |
| Investing Cash Flow | zł-88.09 Million | zł-62.85 Million | zł-63.17 Million | zł-68.06 Million | zł1.50 Million |
| Financing Cash Flow | zł-81.88 Million | zł126.84 Million | zł-64.34 Million | zł156.61 Million | zł175.69 Million |
| Dividends Paid | zł168.44 Million | zł71.89 Million | zł11.00K | zł63.00K | zł22.64 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | — | zł52.07 Million | zł52.07 Million | zł50.62 Million | zł44.45 Million |
| Change in Cash | zł-93.25 Million | zł109.02 Million | zł-17.86 Million | zł12.58 Million | zł-2.22 Million |
Sopharma AD Earnings History — EPS Actual vs. Analyst Estimates
Track Sopharma AD's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jan 30, 2026 | — | — | — |
| Oct 30, 2025 | — | — | — |
| Jul 30, 2025 | — | — | — |
| Jun 30, 2025 | 0.52 | — | — |
| Jan 30, 2025 | 0.16 | — | — |
| Sep 30, 2024 | 0.06 | — | — |
| Jul 30, 2024 | 0.21 | — | — |
| Apr 30, 2024 | 0.50 | — | — |